ACSL4 and renal fibrosis: To explore whether ACSL4 aggravated renal fibrosis by the TGF-β/Smads signaling and the variety of profibrotic factors, ACSL4 inhibitor ROSI was treated in TGF-β-induced TECs and mouse models.